Trade AstraZeneca ^AZN

AstraZeneca Stock And 2 Value Picks Trading Below Cash Flow Estimates

Parallel Advisors LLC Invests $1.72 Million in Astrazeneca Plc $AZN

Temasek Holdings Private Ltd Takes $70.89 Million Position in Astrazeneca Plc $AZN - Stock Observer

Astrazeneca Plc $AZN Shares Sold by Saturna Capital Corp - Daily Political

Does Eplontersen's Phase 3 Miss and Dravet Progress Change The Bull Case For Ionis (IONS)?

FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells

PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight

AstraZeneca Stock And 2 UK Shares Trading Below Cash Flow Value

Burling Wealth Partners LLC Buys Shares of 12,554 Astrazeneca Plc $AZN - Markets Daily

Former AstraZeneca and Novo Nordisk executives join ELRIG Scientific Advisory Board

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know

AstraZeneca Stock And Two UK Value Shares Trading Below Cash Flow Estimates

Astrazeneca Plc $AZN Shares Sold by Boston Common Asset Management LLC

Astrazeneca Plc $AZN Shares Acquired by DekaBank Deutsche Girozentrale

Astrazeneca (AZN) to Release Quarterly Earnings on Monday

AZN Q2 2026 Earnings Report on 7/27/2026

Erste Group Bank Cuts Earnings Estimates for Astrazeneca

AstraZeneca inks $1.5 B deal with China's Dizal Pharma for novel oral EGFR inhibitor Zegfrovy for lung cancer

50,765 Shares in Astrazeneca Plc $AZN Purchased by S&CO Inc.

5,954,417 Shares in Astrazeneca Plc $AZN Purchased by SEB Asset Management AB

Swiss National Bank Takes $1.20 Billion Position in Astrazeneca Plc $AZN - Markets Daily

Jennison Associates LLC Sells 2,698,901 Shares of Astrazeneca Plc $AZN

6,174,666 Shares in Astrazeneca Plc $AZN Bought by Swiss National Bank - Stock Observer

10,918 Shares in Astrazeneca Plc $AZN Purchased by Spartan Wealth Advisory Services LLC - Daily Political

AstraZeneca Stock And 2 Cash Flow Picks Trading Below Fair Value

SEB Asset Management AB Makes New $1.16 Billion Investment in Astrazeneca Plc $AZN - Daily Political

Aurora Investment Counsel Takes $2.53 Million Position in Astrazeneca Plc $AZN

Assetmark Inc. Has $37.69 Million Stake in Astrazeneca Plc $AZN

Is a £500k Stocks and Shares ISA enough to retire in style?

Is NeoGenomics (NEO) Undervalued After Its FDA Approved PTEN Test Launch?

Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis

Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

AstraZeneca Stock And Two UK Cash Flow Picks Trading Below Fair Value

The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?

SouthState Bank Corp Sells 63,327 Shares of Astrazeneca Plc $AZN

Barings LLC Makes New $27.79 Million Investment in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Stake Reduced by Nwam LLC - Daily Political

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

Attractive Growth Profile Positions AstraZeneca PLC (AZN) as Opportunity

Attractive Growth Profile Positions AstraZeneca PLC (AZN) as an Investment Bet

Astrazeneca Plc $AZN Position Lowered by Marks Group Wealth Management Inc

Principal Financial Group Inc. Decreases Position in Astrazeneca Plc $AZN

AZN: Trial Setbacks And Oncology Deals Will Shape Medium Term Credibility

Astrazeneca Plc $AZN Shares Sold by Marks Group Wealth Management Inc - Daily Political

ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS)

Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial

Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models

Checchi Capital Advisers LLC Decreases Stake in Astrazeneca Plc $AZN

169,590 Shares in Astrazeneca Plc $AZN Purchased by Maryland State Retirement & Pension System

Checchi Capital Advisers LLC Trims Stake in Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Sold by Calamos Advisors LLC

AMG National Trust Bank Has $4.72 Million Stake in Astrazeneca Plc $AZN - Zolmax

Calamos Advisors LLC Trims Position in Astrazeneca Plc $AZN - Stock Observer

Recent Research Analysts' Ratings Changes for Astrazeneca (AZN) - Daily Political

Maryland State Retirement & Pension System Buys Shares of 169,590 Astrazeneca Plc $AZN - Daily Political

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma

Promising Manufacturing Stocks To Research - July 14th - Zolmax

4568: Tumor Agnostic Oncology Approvals In Europe Will Drive Future Upside Potential

Sequoia Financial Advisors LLC Sells 19,406 Shares of Astrazeneca Plc $AZN - Zolmax

HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead

IP Federation elects Philips licensing leader as new president

Samsung Electronics denies report that it is exploring US listing

AstraZeneca Secures $1.5 Billion Licensing Deal for Revolutionary Lung Cancer Drug Zegfrovy from China's Dizal Pharma, ETPharma

Astrazeneca Plc $AZN Shares Bought by Diversify Wealth Management LLC

Bleakley Financial Group LLC Sells 23,183 Shares of Astrazeneca Plc $AZN

AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill

AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion | Morningstar

Does NeoGenomics (NEO) New PTEN CDx Move Reveal a Deeper Precision Oncology Strategy Shift?

AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical

Dizal Announces Global Exclusive License Agreement with AstraZeneca for Zegfrovy

Calamos Wealth Management LLC Sells 4,322 Shares of Astrazeneca Plc $AZN - Stock Observer

Carnegie Investment Counsel Reduces Position in Astrazeneca Plc $AZN - Daily Political

AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN) | Morningstar

HSBC downgrades AstraZeneca after key trial failure

AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'

Astrazeneca Plc $AZN Shares Sold by Triglav Investments D.O.O.

Berenberg Bank Sticks to Its Buy Rating for AstraZeneca (AZN)

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Citizens National Bank Trust Department Sells 13,426 Shares of Astrazeneca Plc $AZN - Daily Political

AstraZeneca Stock And 2 UK Value Shares Trading Below Cash Flow Estimates

AstraZeneca helps spark £3bn UK life sciences investment boom

Pittenger & Anderson Inc. Sells 32,448 Shares of Astrazeneca Plc $AZN

Rossmore Private Capital Sells 32,709 Shares of Astrazeneca Plc $AZN

AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage

Ionis Pharmaceuticals (IONS) Faces A Key Setback As Eplontersen Misses In Phase 3

Money Concepts Capital Corp Lowers Stake in Astrazeneca Plc $AZN

AstraZeneca Stock And 2 UK Cash Flow Picks Trading Below Fair Value

How Investors May Respond To Alnylam Pharmaceuticals (ALNY) After Rival ATTR-CM Setback And New Partnerships

AstraZeneca's trial flop raises bigger questions around its pipeline

Is Alnylam Pharmaceuticals (ALNY) Cheap As Rival Trial Failure Shifts ATTR CM Expectations?

Ensemble machine learning for predicting breast cancer recurrence and mortality using clinical and hemogram data

Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up

Top Pharmaceutical Stocks To Follow Now - July 10th

Manufacturing Stocks Worth Watching - July 10th - Stock Observer

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk